Humira (adalimumab) Disease area(s): Immunology Manufacturer(s): AbbVie 2024 Sales (USD): $8.99 billion Why it sold so well: In 2024, Humira remained a significant revenue contributor for AbbVie, despite facing substantial declines due to biosimilar competition following its US loss of exclusivity in January 2023
Through its activation, seladelpar triggers the induction of fibroblast growth factor 21 (FGF21) from hepatocytes, activates c-Jun N-terminal kinase (JNK) signaling pathway, and subsequently inhibits cholesterol 7-hydroxylase (CYP7A1), the rate-limiting enzyme for bile acid synthesis and accumulation
J Allergy Clin Immunol: In Pract 7(7):21512153
For anyone serious about optimizing workouts and achieving measurable results, incorporating L-Carnitine pre workout into a consistent training and nutrition plan is an effective strategy
We also describe a modified version of the triolein-based assay using human serum as a source of endogenous activators and inhibitors and to determine the relative abundance of circulating factors that regulate LPL activity
